» Articles » PMID: 23921753

The Role of Autophagy in Neurodegenerative Disease

Overview
Journal Nat Med
Date 2013 Aug 8
PMID 23921753
Citations 1047
Authors
Affiliations
Soon will be listed here.
Abstract

Autophagy is a lysosomal degradative process used to recycle obsolete cellular constituents and eliminate damaged organelles and protein aggregates. These substrates reach lysosomes by several distinct mechanisms, including delivery within endosomes as well as autophagosomes. Completion of digestion involves dynamic interactions among compartments of the autophagic and endocytic pathways. Neurons are particularly vulnerable to disruptions of these interactions, especially as the brain ages. Not surprisingly, mutations of genes regulating autophagy cause neurodegenerative diseases across the age spectrum with exceptional frequency. In late-onset disorders such as Alzheimer's disease, amyotrophic lateral sclerosis and familial Parkinson's disease, defects arise at different stages of the autophagy pathway and have different implications for pathogenesis and therapy. This Review provides an overview of the role of autophagy in neurodegenerative disease, focusing particularly on less frequently considered lysosomal clearance mechanisms and their considerable impact on disease. Various therapeutic strategies for modulating specific stages of autophagy and the current state of drug development for this purpose are also evaluated.

Citing Articles

NRBF2 plays a crucial role in the acquisition process of learning and memory, independent of the Vps34 complex.

Wu S, Zhuang H, Zhou X, Li K Front Behav Neurosci. 2025; 19:1529522.

PMID: 40013119 PMC: 11861080. DOI: 10.3389/fnbeh.2025.1529522.


Advancements in genetic research and RNA therapy strategies for amyotrophic lateral sclerosis (ALS): current progress and future prospects.

Ruffo P, Traynor B, Conforti F J Neurol. 2025; 272(3):233.

PMID: 40009238 PMC: 11865122. DOI: 10.1007/s00415-025-12975-8.


Posterior cingulate cortex microRNA dysregulation differentiates cognitive resilience, mild cognitive impairment, and Alzheimer's disease.

Counts S, Beck J, Maloney B, Malek-Ahmadi M, Ginsberg S, Mufson E Alzheimers Dement. 2025; 21(2):e70019.

PMID: 40008917 PMC: 11863362. DOI: 10.1002/alz.70019.


Systems-Level Interactome Mapping Reveals Actionable Protein Network Dysregulation Across the Alzheimer's Disease Spectrum.

Bay S, Rodina A, Haut F, Roychowdhury T, Argyrousi E, Staniszewski A Res Sq. 2025; .

PMID: 39989971 PMC: 11844643. DOI: 10.21203/rs.3.rs-5930673/v1.


Effect of Interaction of ATG7 and Plasma Metal Concentrations on Cognitive Impairment in Rural China.

Tang X, Cao J, Cai J, Mo X, Wei Y, He K J Mol Neurosci. 2025; 75(1):27.

PMID: 39988622 DOI: 10.1007/s12031-025-02322-x.


References
1.
Cuervo A, Stefanis L, Fredenburg R, Lansbury P, Sulzer D . Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science. 2004; 305(5688):1292-5. DOI: 10.1126/science.1101738. View

2.
Sasaki S . Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2011; 70(5):349-59. DOI: 10.1097/NEN.0b013e3182160690. View

3.
Fimia G, Stoykova A, Romagnoli A, Giunta L, Di Bartolomeo S, Nardacci R . Ambra1 regulates autophagy and development of the nervous system. Nature. 2007; 447(7148):1121-5. DOI: 10.1038/nature05925. View

4.
Lee S, Sato Y, Nixon R . Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy. J Neurosci. 2011; 31(21):7817-30. PMC: 3351137. DOI: 10.1523/JNEUROSCI.6412-10.2011. View

5.
Steward C . Neurological aspects of osteopetrosis. Neuropathol Appl Neurobiol. 2003; 29(2):87-97. DOI: 10.1046/j.1365-2990.2003.00474.x. View